{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:15:39Z","timestamp":1783574139898,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T00:00:00Z","timestamp":1652313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872340"],"award-info":[{"award-number":["81872340"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072626"],"award-info":[{"award-number":["82072626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12072-022-10338-3","type":"journal-article","created":{"date-parts":[[2022,5,12]],"date-time":"2022-05-12T11:07:01Z","timestamp":1652353621000},"page":"603-613","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Actin-related protein 2\/3 complex subunit 2-enriched extracellular vesicles drive liver cancer metastasis"],"prefix":"10.1007","volume":"16","author":[{"given":"Piaorong","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sze Keong","family":"Tey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Wan Ki","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tung Him","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherlie Lot Sum","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peihua","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-121X","authenticated-orcid":false,"given":"Judy Wai Ping","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,12]]},"reference":[{"issue":"4","key":"10338_CR1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease Study. JAMA Oncol. 2017;3(4):524\u2013548","journal-title":"JAMA Oncol"},{"issue":"2","key":"10338_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u2013132","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10338_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10338_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hep.510290145","volume":"29","author":"JM Llovet","year":"1999","unstructured":"Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29(1):62\u201367","journal-title":"Hepatology"},{"key":"10338_CR5","doi-asserted-by":"publisher","first-page":"m3544","DOI":"10.1136\/bmj.m3544","volume":"371","author":"JD Yang","year":"2020","unstructured":"Yang JD, Heimbach JK. New advances in the diagnosis and management of hepatocellular carcinoma. BMJ. 2020;371:m3544","journal-title":"BMJ"},{"issue":"3","key":"10338_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41575-019-0229-4","volume":"17","author":"AJ Craig","year":"2020","unstructured":"Craig AJ, von Felden J, Garcia-Lezana T, Sarcognato S, Villanueva A. Tumour evolution in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2020;17(3):139\u2013152","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10338_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D\u2019Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213\u2013228","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"10338_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.07.009","volume":"182","author":"A Hoshino","year":"2020","unstructured":"Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, et al. Extracellular vesicle and particle biomarkers define multiple human cancers. Cell. 2020;182(4):1044-1061.e1018","journal-title":"Cell"},{"issue":"12","key":"10338_CR9","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.3390\/cancers13123076","volume":"13","author":"YT Lee","year":"2021","unstructured":"Lee YT, Tran BV, Wang JJ, Liang IY, You S, Zhu Y, et al. The role of extracellular vesicles in disease progression and detection of hepatocellular carcinoma. Cancers (Basel). 2021;13(12):3076","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10338_CR10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.7150\/thno.30958","volume":"9","author":"XP Tian","year":"2019","unstructured":"Tian XP, Wang CY, Jin XH, Li M, Wang FW, Huang WJ, et al. Acidic microenvironment up-regulates exosomal miR-21 and mir-10b in early-stage hepatocellular carcinoma to promote cancer cell proliferation and metastasis. Theranostics. 2019;9(7):1965\u20131979","journal-title":"Theranostics"},{"issue":"3","key":"10338_CR11","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/bjc.2014.621","volume":"112","author":"K Sugimachi","year":"2015","unstructured":"Sugimachi K, Matsumura T, Hirata H, Uchi R, Ueda M, Ueo H, et al. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br J Cancer. 2015;112(3):532\u2013538","journal-title":"Br J Cancer"},{"issue":"1","key":"10338_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13046-020-1529-9","volume":"39","author":"XY Huang","year":"2020","unstructured":"Huang XY, Huang ZL, Huang J, Xu B, Huang XY, Xu YH, et al. Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis. J Exp Clin Cancer Res. 2020;39(1):20","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10338_CR13","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jhep.2019.07.019","volume":"71","author":"Q Guo","year":"2019","unstructured":"Guo Q, Furuta K, Lucien F, Gutierrez Sanchez LH, Hirsova P, Krishnan A, et al. Integrin \u03b2(1)-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. J Hepatol. 2019;71(6):1193\u20131205","journal-title":"J Hepatol"},{"issue":"21","key":"10338_CR14","doi-asserted-by":"publisher","first-page":"2002157","DOI":"10.1002\/advs.202002157","volume":"7","author":"X Mao","year":"2020","unstructured":"Mao X, Tey SK, Yeung CLS, Kwong EML, Fung YME, Chung CYS, et al. Nidogen 1-enriched extracellular vesicles facilitate extrahepatic metastasis of liver cancer by activating pulmonary fibroblasts to secrete tumor necrosis factor receptor 1. Adv Sci (Weinh). 2020;7(21):2002157","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10338_CR15","doi-asserted-by":"publisher","first-page":"e12031","DOI":"10.1002\/jev2.12031","volume":"10","author":"X Mao","year":"2020","unstructured":"Mao X, Zhou L, Tey SK, Ma APY, Yeung CLS, Ng TH, et al. Tumour extracellular vesicle-derived Complement Factor H promotes tumorigenesis and metastasis by inhibiting complement-dependent cytotoxicity of tumour cells. J Extracell Vesicles. 2020;10(1):e12031","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"10338_CR16","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.jhep.2021.12.005","volume":"76","author":"SK Tey","year":"2022","unstructured":"Tey SK, Wong SWK, Chan JYT, Mao X, Tung HN, Yeung CLS, et al. Patient pIgR-enriched extracellular vesicles drive cancer stemness, tumorigenesis and metastasis in hepatocellular carcinoma. J Hepatol. 2022;76(4):883\u2013895","journal-title":"J Hepatol."},{"issue":"5547","key":"10338_CR17","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1126\/science.1066333","volume":"294","author":"RC Robinson","year":"2001","unstructured":"Robinson RC, Turbedsky K, Kaiser DA, Marchand JB, Higgs HN, Choe S, et al. Crystal structure of Arp2\/3 complex. Science. 2001;294(5547):1679\u20131684","journal-title":"Science"},{"key":"10338_CR18","doi-asserted-by":"publisher","first-page":"690151","DOI":"10.3389\/fmolb.2021.690151","volume":"8","author":"S Huang","year":"2021","unstructured":"Huang S, Li D, Zhuang L, Sun L, Wu J. Identification of Arp2\/3 complex subunits as prognostic biomarkers for hepatocellular carcinoma. Front Mol Biosci. 2021;8:690151","journal-title":"Front Mol Biosci"},{"issue":"10","key":"10338_CR19","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Cancer Genome Atlas Research N, Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, et al. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45(10):1113\u20131120","journal-title":"Nat Genet"},{"issue":"4","key":"10338_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.gpb.2018.07.003","volume":"16","author":"Q Lian","year":"2018","unstructured":"Lian Q, Wang S, Zhang G, Wang D, Luo G, Tang J, et al. HCCDB: a database of hepatocellular carcinoma expression atlas. Genom Proteom Bioinform. 2018;16(4):269\u2013275","journal-title":"Genom Proteom Bioinform"},{"issue":"2","key":"10338_CR21","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1083\/jcb.201112113","volume":"197","author":"P Suraneni","year":"2012","unstructured":"Suraneni P, Rubinstein B, Unruh JR, Durnin M, Hanein D, Li R. The Arp2\/3 complex is required for lamellipodia extension and directional fibroblast cell migration. J Cell Biol. 2012;197(2):239\u2013251","journal-title":"J Cell Biol"},{"issue":"9","key":"10338_CR22","doi-asserted-by":"publisher","first-page":"3930","DOI":"10.1091\/mbc.e06-06-0500","volume":"17","author":"DJ Frank","year":"2006","unstructured":"Frank DJ, Hopmann R, Lenartowska M, Miller KG. Capping protein and the Arp2\/3 complex regulate nonbundle actin filament assembly to indirectly control actin bundle positioning during Drosophila melanogaster bristle development. Mol Biol Cell. 2006;17(9):3930\u20133939","journal-title":"Mol Biol Cell"},{"issue":"5","key":"10338_CR23","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.3892\/or.2013.2669","volume":"30","author":"Z Liu","year":"2013","unstructured":"Liu Z, Yang X, Chen C, Liu B, Ren B, Wang L, et al. Expression of the Arp2\/3 complex in human gliomas and its role in the migration and invasion of glioma cells. Oncol Rep. 2013;30(5):2127\u20132136","journal-title":"Oncol Rep"},{"issue":"4","key":"10338_CR24","first-page":"1387","volume":"54","author":"P Chen","year":"2019","unstructured":"Chen P, Yue X, Xiong H, Lu X, Ji Z. RBM3 upregulates ARPC2 by binding the 3\u2019UTR and contributes to breast cancer progression. Int J Oncol. 2019;54(4):1387\u20131397","journal-title":"Int J Oncol"},{"key":"10338_CR25","doi-asserted-by":"publisher","first-page":"e00884","DOI":"10.7554\/eLife.00884","volume":"2","author":"LA Helgeson","year":"2013","unstructured":"Helgeson LA, Nolen BJ. Mechanism of synergistic activation of Arp2\/3 complex by cortactin and N-WASP. Elife. 2013;2:e00884","journal-title":"Elife"},{"issue":"2","key":"10338_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1083\/jcb.201601025","volume":"214","author":"S Sinha","year":"2016","unstructured":"Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, et al. Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol. 2016;214(2):197\u2013213","journal-title":"J Cell Biol"},{"issue":"6","key":"10338_CR27","first-page":"3189","volume":"41","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, Wei W, Wu Z, Wang J, Ding X, Sheng Y, et al. ARPC2 promotes breast cancer proliferation and metastasis. Oncol Rep. 2019;41(6):3189\u20133200","journal-title":"Oncol Rep"},{"key":"10338_CR28","first-page":"5432818","volume":"2017","author":"J Zhang","year":"2017","unstructured":"Zhang J, Liu Y, Yu CJ, Dai F, Xiong J, Li HJ, et al. Role of ARPC2 in human gastric cancer. Mediat Inflamm. 2017;2017:5432818","journal-title":"Mediat Inflamm"},{"issue":"12","key":"10338_CR29","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1111\/cas.14205","volume":"110","author":"J Choi","year":"2019","unstructured":"Choi J, Lee YJ, Yoon YJ, Kim CH, Park SJ, Kim SY, et al. Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2\/3 complex. Cancer Sci. 2019;110(12):3788\u20133801","journal-title":"Cancer Sci"},{"key":"10338_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.bcp.2019.01.017","volume":"163","author":"YJ Yoon","year":"2019","unstructured":"Yoon YJ, Han YM, Choi J, Lee YJ, Yun J, Lee SK, et al. Benproperine, an ARPC2 inhibitor, suppresses cancer cell migration and tumor metastasis. Biochem Pharmacol. 2019;163:46\u201359","journal-title":"Biochem Pharmacol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10338-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10338-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10338-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T01:07:37Z","timestamp":1654650457000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10338-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,12]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10338"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10338-3","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,12]]},"assertion":[{"value":"29 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Delarations"}},{"value":"Piaorong Mei, Sze Keong Tey, Samuel Wan Ki Wong, Tung Him Ng, Xiaowen Mao, Cherlie Lot Sum Yeung, Yi Xu, Liang Yu, Qianhua Huang, Peihua Cao, Judy Wai Ping Yam, Yi Gao have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal studies were approved by the Committee of the Use of Live Animals in Teaching and Research (CULATR), The University of Hong Kong. All animal work and procedures were followed strictly according to the Animals (Control of Experiments) Ordinance (Hong Kong) and the Institute\u2019s guidance from Centre for Comparative Medical Research (CCMR), Li Ka Shing Faculty of Medicine, The University of Hong Kong.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}